Calkins Daniel 4
4 · Verastem, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Verastem, Inc.VSTM
Calkins Daniel
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-01-06$6.94/sh−6$42→ 47,639 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.
- [F2]Includes 277 shares of common stock purchased pursuant to the Issuer's 2018 Employee Stock Purchase Plan.